#1
#1 out of 11.7K est. views
politics17h ago
Trump administration science assault slams major Bay Area economic engine, threatens ‘amazing innovations’
- Bay Area biotech leaders say federal funding cuts and policy shifts are rattling investors and delaying programs.
- Industry groups say Bay Area biotech received billions in NIH funds and jobs, but funding is now unclear.
- Executives warn that reduced funding could slow drug development and hinder patient care.
- Analysts say policy clashes risk handing biotech leadership to other nations.
- Researchers report disruptions to NIH-funded studies and delays in trials nationwide.
- Bay Area universities and research hubs remain a key source of drug development and startups.
- Industry voices call for policy balance to protect innovation and patient outcomes.
- Executives warn ongoing cuts may erode the Bay Area’s role as an economic engine.
- Investors and researchers advocate for policy clarity to preserve science-led growth.
- Regional NIH funding losses compound broader declines in federal science support.
Vote 0